Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
Open Access
- 1 September 2015
- journal article
- Published by American Society for Microbiology in mBio
- Vol. 6 (4), e01120
- https://doi.org/10.1128/mbio.01120-15
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus InfectionmBio, 2015
- Middle East respiratory syndromeThe Lancet, 2015
- Middle East respiratory syndrome in the shadow of EbolaThe Lancet. Respiratory Medicine, 2015
- Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxideBMC Pharmacology and Toxicology, 2014
- Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathwayBiochemical and Biophysical Research Communications, 2014
- Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases SurvivalJournal of Virology, 2014
- Drugs to cure avian influenza infection – multiple ways to prevent cell deathCell Death & Disease, 2013
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for PathogenesisThe Journal of Infectious Diseases, 2013
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoVPLoS Pathogens, 2008
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung InjuryCell, 2008